Inctye’s Pemazyre authorised in the EU for bile duct cancer by Lucy Parsons | Mar 30, 2021 | News | 0 Kinase inhibitor authorised to treat advanced bile duct cancer patients with a FGFR2 fusion or rearrangement Read More
US clears first targeted treatment for cholangiocarcinoma by Selina McKee | Apr 20, 2020 | News | 0 Incyte’s Pemazyre can now be used to treat the bile duct cancer. The firm has also launched a global COVID-19 trial Read More